Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Sygnature Discovery named as Finalist in 2019 OBN Award Best CRO

Sygnature Discovery is pleased to announce that we are a finalist in the OBN Awards 2019 Best Contract Research Organisation category.

The OBN Awards 2019, now in its 11th year, celebrates innovation and outstanding achievement across the UK Life Sciences industry. Categories are broad ranging and include Biotech, Medtech, Synthetic Biology, Digital Healthcare and Investment.

The Awards dinner will take place on Thursday 7th November 2019 at Examinations School in Oxford.  For more information on the OBN Awards 2019, go to:

Sygnature won Best CRO in 2017, in the first year of the category and we are hoping to repeat the endorsement.

Sygnature Discovery collecting Best Contract Research Organisation Award at OBN Awards 2017

Sygnature Discovery won Best Contract Research Organisation Award at the OBN Awards 2017

Latest News

View All

Sygnature Discovery and Daewoong Pharma announce research…

New platform set to accelerate early-stage targeted…

Sygnature Discovery completes acquisition of SB Drug…

Sygnature Discovery partners the Oncology Development Programme…